Menopause marks a significant phase in a woman’s life, bringing various physical, emotional, and mental changes. Addressing menopause and hormone therapy is crucial for maintaining women’s health and quality of life. In recent years, femtech has emerged, offering innovative and accessible healthcare solutions that are transforming women’s health. The Impact of Menopause on Women’s Health Menopause brings challenges that can significantly affect…
Babylist, a platform trusted by millions of growing families for its wide range of products and services across commerce, media, and health, has announced an expansion of its health offerings. This move aims to provide expecting and new parents with easier and more transparent access to health and wellness products during pregnancy and postpartum. The expansion includes broader coverage with breast pump…
Motherhood Care+, a femtech based in Malaysia, has successfully completed a seed funding round led by Care Ventures Group, a fund specializing in healthcare, wellness, medical, and AI technologies. The funding, finalized in December 2023 & announced earlier this month, marks a significant step for the female-led and female-founded company. Founded in May 2023 by Tan Yew Aik and Goh Shze Yinn,…
You’ve found some of our exclusive Inner Circle Content. This article is only available for our Inner Circle Members. To read on: Sign in to your Inner Circle account to access this content. If you aren’t a member yet and would like to find out more about our Inner Circle program or sign up, click here.
3Daughters, a clinical development company dedicated to advancing women’s healthcare, has announced the successful completion of an oversubscribed seed financing round, raising $4.7 million. This round saw participation from existing investors including Thairm Bio, Argosy Foundation, Wexford Science and Technology, UMass Amherst, and new undisclosed investors. Mary Beth Cicero, CEO of 3Daughters, commented: “We are thrilled by the overwhelming response from both…
Novocuff, a medical device company focused on improving pregnancy outcomes and reducing preterm births, has successfully closed an oversubscribed $26 million Series A funding round. The round was led by AXA IM Alts, through its Global Healthcare Private Equity Strategy, with a $14 million investment. Significant participation also came from Laerdal Million Lives Fund, along with continued support from existing and new…
Every Thursday we send out a curated newsletter on all things femtech and women’s health innovation. This is an excerpt from the latest edition. If you’d like to subscribe, you can do so at the bottom of this page. Highlights Seven Starling raises $10.9M in Series A funding to expand access to specializd women’s behavioral health services. Kindred Health adds $5.5M in funding to transform women’s health in…
Global pharmaceutical company Lupin has announced the divestiture of its U.S. Commercial Women’s Health Specialty Business to Evofem Biosciences, a biopharmaceutical company dedicated to women’s health. This strategic move includes the transfer of SOLOSEC (secnidazole) 2g oral granules, an FDA-approved antimicrobial agent for treating bacterial vaginosis (BV) and trichomoniasis. The agreement provides Lupin with the opportunity to receive up to USD 84…
